标题
Influenza immunology evaluation and correlates of protection: a focus on vaccines
作者
关键词
-
出版物
Expert Review of Vaccines
Volume 15, Issue 8, Pages 967-976
出版商
Informa UK Limited
发表日期
2016-03-09
DOI
10.1586/14760584.2016.1164046
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Assessment of Prime-boost Vaccination Using an AS03B-adjuvanted Influenza A (H5N1) Vaccine
- (2016) Patricia Izurieta et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Current and next generation influenza vaccines: Formulation and production strategies
- (2015) Peter C. Soema et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Flucelvax (Optaflu) for seasonal influenza
- (2015) Ilaria Manini et al. Expert Review of Vaccines
- Validation of Single Radial Haemolysis assay: A reliable method to measure antibodies against influenza viruses
- (2015) Claudia Maria Trombetta et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Antibody to Influenza Virus Neuraminidase: An Independent Correlate of Protection
- (2015) Arnold S. Monto et al. JOURNAL OF INFECTIOUS DISEASES
- Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection
- (2015) Hadi M Yassine et al. NATURE MEDICINE
- A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen
- (2015) A. Impagliazzo et al. SCIENCE
- Safety and immunogenicity of an MF59®-adjuvanted A/H1N1 pandemic influenza vaccine in children from three to seventeen years of age
- (2015) Markus Knuf et al. VACCINE
- Long term effectiveness of adjuvanted influenza A(H1N1)pdm09 vaccine in children
- (2015) Åke Örtqvist et al. VACCINE
- Safety and persistence of the humoral and cellular immune responses induced by 2 doses of an AS03-adjuvanted A(H1N1)pdm09 pandemic influenza vaccine administered to infants, children and adolescents: Two open, uncontrolled studies
- (2015) José Garcia-Sicilia et al. Human Vaccines & Immunotherapeutics
- Immunogenicity and safety of cell-derived MF59®-adjuvanted A/H1N1 influenza vaccine for children
- (2015) Markus Knuf et al. Human Vaccines & Immunotherapeutics
- Development of Cross-Protective Influenza A Vaccines Based on Cellular Responses
- (2015) Peter Christiaan Soema et al. Frontiers in Immunology
- Pseudotype-Based Neutralization Assays for Influenza: A Systematic Analysis
- (2015) George William Carnell et al. Frontiers in Immunology
- Microneutralization Assay Titres Correlate with Protection against Seasonal Influenza H1N1 and H3N2 in Children
- (2015) Chris P. Verschoor et al. PLoS One
- Heterologous Prime-Boost Vaccination Using an AS03B-Adjuvanted Influenza A(H5N1) Vaccine in Infants and Children
- (2014) Terry Nolan et al. JOURNAL OF INFECTIOUS DISEASES
- Association Between Antibody Titers and Protection Against Influenza Virus Infection Within Households
- (2014) Tim K. Tsang et al. JOURNAL OF INFECTIOUS DISEASES
- Immunogenicity and Tolerability of an MF59-adjuvanted, Egg-derived, A/H1N1 Pandemic Influenza Vaccine in Children 6–35 Months of Age
- (2014) Markus Knuf et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Long-term outcome of the humoral and cellular immune response of an H5N1 adjuvanted influenza vaccine in elderly persons: 2-year follow-up of a randomised open-label study
- (2014) Paul Gillard et al. Trials
- Enhanced and persistent antibody response against homologous and heterologous strains elicited by a MF59®-adjuvanted influenza vaccine in infants and young children
- (2014) Terry Nolan et al. VACCINE
- Immunogenicity, reactogenicity, and safety of inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine in healthy adults aged ≥18 years: A phase III, randomized trial
- (2014) Juan Carlos Tinoco et al. VACCINE
- Comparison of the safety and immunogenicity of an MF59®-adjuvanted with a non-adjuvanted seasonal influenza vaccine in elderly subjects
- (2014) Sharon E. Frey et al. VACCINE
- Fast vaccine design and development based on correlates of protection (COPs): Influenza as a trendsetter
- (2014) Cécile van Els et al. Human Vaccines & Immunotherapeutics
- A dose-ranging study of MF59®-adjuvanted and non-adjuvanted A/H1N1 pandemic influenza vaccine in young to middle-aged and older adult populations to assess safety, immunogenicity, and antibody persistence one year after vaccination
- (2014) Keith S Reisinger et al. Human Vaccines & Immunotherapeutics
- Immunogenicity and Reactogenicity of an Inactivated Quadrivalent Influenza Vaccine Administered Intramuscularly to Children 6 to 35 Months of Age in 2012–2013: A Randomized, Double-Blind, Controlled, Multicenter, Multicountry, Clinical Trial
- (2014) Joanne M. Langley et al. Journal of the Pediatric Infectious Diseases Society
- Immunogenicity and safety of quadrivalent versus trivalent inactivated influenza vaccine: a randomized, controlled trial in adults
- (2013) Jiří Beran et al. BMC INFECTIOUS DISEASES
- Immunological assessment of influenza vaccines and immune correlates of protection
- (2013) Adrian Reber et al. Expert Review of Vaccines
- Antibody Correlates and Predictors of Immunity to Naturally Occurring Influenza in Humans and the Importance of Antibody to the Neuraminidase
- (2013) Robert B. Couch et al. JOURNAL OF INFECTIOUS DISEASES
- Neuraminidase-Inhibiting Antibody Is a Correlate of Cross-Protection against Lethal H5N1 Influenza Virus in Ferrets Immunized with Seasonal Influenza Vaccine
- (2013) S. Rockman et al. JOURNAL OF VIROLOGY
- Cellular immune correlates of protection against symptomatic pandemic influenza
- (2013) Saranya Sridhar et al. NATURE MEDICINE
- Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a bayesian random-effects model
- (2012) Laurent Coudeville et al. BMC Medical Research Methodology
- Nomenclature for Immune Correlates of Protection After Vaccination
- (2012) S. A. Plotkin et al. CLINICAL INFECTIOUS DISEASES
- The 2009 pandemic H1N1 virus induces anti-neuraminidase (NA) antibodies that cross-react with the NA of H5N1 viruses in ferrets
- (2012) Zhongying Chen et al. VACCINE
- Cell culture (Vero cell) derived whole-virus non-adjuvanted H5N1 influenza vaccine induces long-lasting cross-reactive memory immune response: Homologous or heterologous booster response following two dose or single dose priming
- (2012) Maikel V.W. van der Velden et al. VACCINE
- Enhancing the reproducibility of serological methods used to evaluate immunogenicity of pandemic H1N1 influenza vaccines—An effective EU regulatory approach
- (2012) Ralf Wagner et al. VACCINE
- Safety and immunogenicity of a quadrivalent inactivated influenza vaccine compared to licensed trivalent inactivated influenza vaccines in adults
- (2012) David P. Greenberg et al. VACCINE
- Protection against a lethal H5N1 influenza challenge by intranasal immunization with virus-like particles containing 2009 pandemic H1N1 neuraminidase in mice
- (2012) Judith D. Easterbrook et al. VIROLOGY
- Correlates of vaccine protection from influenza and its complications
- (2012) Jonathan A. McCullers et al. Human Vaccines & Immunotherapeutics
- Serologic assays for influenza surveillance, diagnosis and vaccine evaluation
- (2011) Jacqueline M Katz et al. Expert Review of Anti-Infective Therapy
- A new approach to estimate vaccine efficacy based on immunogenicity data applied to influenza vaccines administered by the intradermal or intramuscular routes
- (2011) Laurent Coudeville et al. Human vaccines & immunotherapeutics
- Sensitivity and Specificity of Serologic Assays for Detection of Human Infection with 2009 Pandemic H1N1 Virus in U.S. Populations
- (2011) Vic Veguilla et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Population exposure to a novel influenza A virus over three waves of infection
- (2011) W.E. Adamson et al. JOURNAL OF CLINICAL VIROLOGY
- Influenza Hemagglutination-Inhibition Antibody Titer as a Correlate of Vaccine-Induced Protection
- (2011) Suzanne E. Ohmit et al. JOURNAL OF INFECTIOUS DISEASES
- Efficacy Studies of Influenza Vaccines: Effect of End Points Used and Characteristics of Vaccine Failures
- (2011) Joshua G. Petrie et al. JOURNAL OF INFECTIOUS DISEASES
- A Vero Cell–Derived Whole-Virus H5N1 Vaccine Effectively Induces Neuraminidase-Inhibiting Antibodies
- (2011) Richard Fritz et al. JOURNAL OF INFECTIOUS DISEASES
- Live and Inactivated Influenza Vaccines Induce Similar Humoral Responses, but Only Live Vaccines Induce Diverse T-Cell Responses in Young Children
- (2011) Daniel F. Hoft et al. JOURNAL OF INFECTIOUS DISEASES
- Efficacy, safety, and immunogenicity of a Vero-cell-culture-derived trivalent influenza vaccine: a multicentre, double-blind, randomised, placebo-controlled trial
- (2011) P Noel Barrett et al. LANCET
- Hemagglutination Inhibition Antibody Titers as a Correlate of Protection for Inactivated Influenza Vaccines in Children
- (2011) Steven Black et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Towards universal influenza vaccines?
- (2011) A. Osterhaus et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- H5N1 Whole-Virus Vaccine Induces Neutralizing Antibodies in Humans Which Are Protective in a Mouse Passive Transfer Model
- (2011) M. Keith Howard et al. PLoS One
- Registration of influenza vaccines for children in Europe
- (2011) Marta Granström et al. VACCINE
- Evaluation of a virosomal H5N1 vaccine formulated with Matrix M™ adjuvant in a phase I clinical trial
- (2011) Rebecca J. Cox et al. VACCINE
- Immunogenicity and safety of inactivated monovalent 2009 H1N1 influenza A vaccine in immunocompromised children and young adults
- (2011) Hana Hakim et al. VACCINE
- Influenza vaccine responses in older adults
- (2010) Janet E. McElhaney AGEING RESEARCH REVIEWS
- Validation of the safety of MDCK cells as a substrate for the production of a cell-derived influenza vaccine
- (2010) David Onions et al. BIOLOGICALS
- Human influenza vaccines and assessment of immunogenicity
- (2010) Zichria Zakay-Rones Expert Review of Vaccines
- Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study
- (2010) Elizabeth Miller et al. LANCET
- Determination of serum antibodies against swine-origin influenza A virus H1N1/09 by immunofluorescence, haemagglutination inhibition, and by neutralization tests: how is the prevalence rate of protecting antibodies in humans?
- (2010) Regina Allwinn et al. MEDICAL MICROBIOLOGY AND IMMUNOLOGY
- The Efficacy of Live Attenuated and Inactivated Influenza Vaccines in Children as a Function of Time Postvaccination
- (2010) Christopher S. Ambrose et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Specific Recognition of Influenza A/H1N1/2009 Antibodies in Human Serum: A Simple Virus-Free ELISA Method
- (2010) Mario M. Alvarez et al. PLoS One
- Safety and immunogenicity of an inactivated split-virus influenza A/H1N1 vaccine in healthy children from 6 months to
- (2010) Chi-Eun Oh et al. VACCINE
- Qualification of the Hemagglutination Inhibition Assay in Support of Pandemic Influenza Vaccine Licensure
- (2009) D. L. Noah et al. Clinical and Vaccine Immunology
- Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels
- (2009) G. Galli et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MF59®-adjuvanted influenza vaccine (FLUAD®) in children: Safety and immunogenicity following a second year seasonal vaccination
- (2009) T. Vesikari et al. VACCINE
- MF59-adjuvanted versus non-adjuvanted influenza vaccines: Integrated analysis from a large safety database
- (2009) Michele Pellegrini et al. VACCINE
- Vaccines: Correlates of Vaccine‐Induced Immunity
- (2008) Stanley A. Plotkin CLINICAL INFECTIOUS DISEASES
- Testing human sera for antibodies against avian influenza viruses: Horse RBC hemagglutination inhibition vs. microneutralization assays
- (2008) Ghazi Kayali et al. JOURNAL OF CLINICAL VIROLOGY
- Cross-Recognition of Avian H5N1 Influenza Virus by Human Cytotoxic T-Lymphocyte Populations Directed to Human Influenza A Virus
- (2008) J. H. C. M. Kreijtz et al. JOURNAL OF VIROLOGY
- A Clinical Trial of a Whole-Virus H5N1 Vaccine Derived from Cell Culture
- (2008) Hartmut J. Ehrlich et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now